Compare CARE & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CARE | CTKB |
|---|---|---|
| Founded | 1974 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 723.5M | 777.3M |
| IPO Year | 2020 | 2021 |
| Metric | CARE | CTKB |
|---|---|---|
| Price | $29.04 | $5.53 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $34.08 | $6.50 |
| AVG Volume (30 Days) | 166.7K | ★ 1.2M |
| Earning Date | 10-29-2026 | 11-04-2026 |
| Dividend Yield | ★ 1.37% | N/A |
| EPS Growth | ★ 30.19 | N/A |
| EPS | ★ 5.53 | N/A |
| Revenue | $20,315,000.00 | ★ $193,015,000.00 |
| Revenue This Year | $76.15 | $3.83 |
| Revenue Next Year | N/A | $6.48 |
| P/E Ratio | $5.29 | ★ N/A |
| Revenue Growth | 4.65 | ★ 17.67 |
| 52 Week Low | $16.86 | $3.31 |
| 52 Week High | $36.06 | $6.34 |
| Indicator | CARE | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 42.79 | 46.36 |
| Support Level | $28.27 | $4.10 |
| Resistance Level | $31.02 | $6.27 |
| Average True Range (ATR) | 0.74 | 0.34 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 28.06 | 19.90 |
Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.